Denosumab and the current status of bone-modifying drugs in breast cancer. [electronic resource]
Producer: 20120412Description: 157-67 p. digitalISSN:- 1651-226X
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Bone Density Conservation Agents -- therapeutic use
- Bone Neoplasms -- prevention & control
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Clinical Trials, Phase III as Topic
- Denosumab
- Diphosphonates -- therapeutic use
- Female
- Humans
- Osteoporosis -- chemically induced
- Randomized Controlled Trials as Topic
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.